AVALO THERAPEUTICS INC
(NASDAQ: AVTX)
Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.
15.940
+0.960
(+6.41%)
Range
14.690 - 16.225
(10.45%)
Open
15.000
Previous Close
14.980
Bid Price
2.900
Bid Volume
11
Ask Price
3.020
Ask Volume
11
Volume
78,226
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis